Earnings Neutral 5

Superior Group (SGC) EPS Nearly Doubles in Q4 on Branded Products Growth

· 3 min read · Verified by 2 sources · By Finance Intelligence Brief Editorial
Share

Key Takeaways

  • Superior Group of Companies (SGC) reported a significant bottom-line beat for Q4 2025, with diluted EPS rising to $0.23 from $0.13 a year prior.
  • While revenue growth was modest at 1%, the company's strategic acquisition of Three Point and aggressive SG&A reductions drove a 19% increase in EBITDA.

Mentioned

Superior Group of Companies, Inc. company SGC Michael Benstock person Michael W. Koempel person Jake Himelstein person Three Point company

Key Intelligence

Key Facts

  1. 1Diluted EPS rose to $0.23, nearly doubling the $0.13 reported in Q4 2024.
  2. 2Consolidated revenue reached $147 million, up 1% year-over-year and 6% sequentially.
  3. 3Branded Products revenue grew 5% to $97 million, aided by the Three Point acquisition.
  4. 4SG&A expenses were reduced by $1.4 million, falling to 33.2% of total sales.
  5. 5Total liquidity exceeds $100 million, with $24 million in cash and equivalents at year-end.
  6. 6EBITDA increased 19% to $8.6 million, with margins expanding to 5.9%.
Segment
Branded Products $97M +5% 34.4%
Healthcare Apparel $29M -5% 33.6%
Contact Centers $22M -8% 52.6%

Analysis

Superior Group of Companies (SGC) delivered a robust Q4 2025 performance that highlights a successful pivot toward higher-margin branded products and rigorous operational efficiency. Despite a challenging macroeconomic environment that weighed on its healthcare and contact center segments, the company managed to nearly double its diluted earnings per share year-over-year, rising from $0.13 to $0.23. This bottom-line surge was driven by a combination of strategic acquisitions and a significant reduction in overhead costs, signaling a leaner and more resilient business model.

The Branded Products segment has emerged as the clear engine of growth for SGC. Revenue in this division climbed 5% year-over-year to $97 million, bolstered by the integration of the Three Point acquisition. Sequentially, the segment saw a more dramatic $10 million increase, reflecting both organic momentum and the additive impact of the new acquisition. Notably, Branded Products gross margins expanded by 50 basis points to 34.4%, a feat achieved despite the headwinds of higher tariffs. This suggests strong pricing power and effective supply chain management in a volatile trade environment.

Despite a challenging macroeconomic environment that weighed on its healthcare and contact center segments, the company managed to nearly double its diluted earnings per share year-over-year, rising from $0.13 to $0.23.

In contrast, the Healthcare Apparel and Contact Centers segments faced ongoing structural and cyclical challenges. Healthcare revenue fell 5% to $29 million, as management pointed to "macro uncertainty" affecting both wholesale and institutional healthcare channels. This reflects a broader trend in the medical uniform industry where hospital systems have become more conservative with discretionary spending. Meanwhile, the Contact Centers segment saw an 8% revenue decline to $22 million, primarily due to customer attrition. However, management noted sequential stabilization, indicating that the impact of the Jamaica center closure is beginning to bottom out as new business wins start to offset previous losses.

What to Watch

The most critical driver of the Q4 beat was SGC’s focus on cost containment. Selling, General, and Administrative (SG&A) expenses were reduced by $1.4 million compared to the prior-year period. As a percentage of sales, SG&A dropped from 34.4% to 33.2%. This discipline allowed the company to expand its EBITDA margin by 90 basis points to 5.9%, even as consolidated revenue growth remained a modest 1%. The ability to grow EBITDA by 19% on such slim top-line growth underscores the management team's success in optimizing the company's cost structure.

Looking forward, SGC enters 2026 with a strong balance sheet and significant dry powder. With over $100 million in total liquidity and $24 million in cash on hand, the company is well-positioned to pursue further M&A opportunities or invest in organic growth initiatives. Investors should watch for continued stabilization in the healthcare segment and the potential for the Branded Products division to further scale as the Three Point integration matures. The company's back-end-weighted cadence in 2025 sets a high bar for the coming year, but its improved margin profile provides a solid foundation for sustained earnings growth.

Timeline

Timeline

  1. Fiscal Year End

  2. Q4 Earnings Release

  3. Earnings Call

Sources

Sources

Based on 2 source articles

Related Stories

Earnings

Adobe Q2: $6.62B Revenue, $410 DCF Target — 40%+ Upside

Adobe’s Q2 FY26 beat estimates with $6.62B revenue, guidance raised to $26.55B. A DCF model suggests a $410 target price, implying over 40% upside. Margin resilience and AI ARR growth counterbalance governance risks.

Earnings

Monash IVF Slashes Profit Outlook by 15% as Australian Cycles Decline

Monash IVF cuts FY26 profit guidance to $17-18M, citing a 4.7% drop in ART cycles, while fending off a $0.90 takeover bid. The financial story now hinges on cost-cutting, international growth, and the possibility of a renewed offer.

Earnings

Global-E's Mixed Q1 Drives 10% Market Volatility

Investors are reacting to Global-E Online's mixed Q1 earnings and elevated FY26 outlook, with potential ripple effects on market indices and tech stocks. This event highlights regulatory and economic factors influencing finance, urging analysts to assess risk in earnings reports. Finance professionals should focus on how these results tie into broader market trends and investor sentiment.

Earnings

Figure Tech Beats Estimates by 15%, Boosting Stock

Figure Technology Solutions' Q1 earnings exceeded expectations, driving potential stock gains and influencing market trends. Investors should note the positive Q2 outlook amid broader economic uncertainties, highlighting opportunities in resilient tech stocks. This development underscores the importance of earnings data in shaping financial strategies.

How we covered this story

Every story in our finance coverage is assembled from multiple primary sources, cross-referenced for factual consistency, and scored along three independent dimensions: sentiment, operational impact, and source-cluster confidence. Single-source rumors and unverifiable claims do not pass our editorial gate. When a story shows "Verified by N sources" with N≥2, the development is independently corroborated; when N=1, we mark it explicitly so readers can weigh the signal accordingly.

Impact scoring uses a 1-10 scale weighted toward regulatory, financial, and operational consequence rather than coverage volume. A topic that runs in every outlet but moves no real decisions ranks lower than a niche regulatory filing that reshapes how operators in the finance space have to behave. Read our full methodology for the scoring rubric, our glossary for term definitions, and our trends index for the longitudinal view across the beat.

Signal on this pageWhat it tells you
Verified by N sourcesIndependent corroboration count. N≥2 is our confidence floor; N=1 is marked explicitly.
Impact score (1-10)Regulatory + financial + operational weight. 8+ signals an experienced-operator action item.
SentimentFive-tier classification trained on labeled finance-specific corpora.
TimelineWhere applicable, the related-events sequence that contextualizes today's development.